Abstract Details
|
Xuling Lin, MD
(National Neuroscience Institute)
PRESENTER |
The institution of Dr. Lin has received research support from National Health Innovation Center. |
| No disclosure on file | |
| Marc Rosenblum | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Adrienne Boire, MD, PhD, FAAN (Memorial Sloan-Kettering) | Dr. Boire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apelis Pharmaceuticals. The institution of Dr. Boire has received research support from National Cancer Institute. The institution of Dr. Boire has received research support from Center for Experimental Therapeutics. The institution of Dr. Boire has received research support from STARR Cancer Consortium. The institution of Dr. Boire has received research support from National Cancer Institute. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| No disclosure on file | |
| Lisa M. DeAngelis, MD, FAAN (Memorial Sloan-Kettering Cancer Center) | Dr. DeAngelis has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Antonio M. Omuro, MD, FAAN (Stanford University) | Dr. Omuro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as a Consultant for Kiyatec. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curevac. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Neurology. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Agios. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Denovo Biopharma. |
| Elena Pentsova, MD (Memorial Sloan-Kettering Cancer Center) | The institution of Dr. Pentsova has received research support from YmAbs Therapeutics, Inc. |